Filter News
Area of Research
- (-) Supercomputing (21)
- Biology and Environment (25)
- Clean Energy (24)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Energy Frontier Research Centers (1)
- Fusion and Fission (3)
- Isotope Development and Production (1)
- Isotopes (7)
- Materials (46)
- Materials for Computing (6)
- National Security (4)
- Neutron Science (42)
- Nuclear Science and Technology (4)
News Topics
- (-) Biomedical (5)
- (-) Environment (3)
- (-) Isotopes (1)
- (-) Microscopy (5)
- (-) Nanotechnology (5)
- (-) Neutron Science (7)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (12)
- Big Data (1)
- Bioenergy (6)
- Biology (4)
- Biotechnology (1)
- Buildings (1)
- Chemical Sciences (3)
- Climate Change (3)
- Computer Science (31)
- Coronavirus (5)
- Cybersecurity (6)
- Decarbonization (1)
- Energy Storage (5)
- Exascale Computing (7)
- Frontier (12)
- Grid (3)
- High-Performance Computing (11)
- Machine Learning (5)
- Materials (8)
- Materials Science (6)
- Molten Salt (1)
- National Security (5)
- Nuclear Energy (1)
- Partnerships (1)
- Physics (4)
- Quantum Computing (5)
- Quantum Science (10)
- Security (4)
- Simulation (1)
- Summit (14)
- Sustainable Energy (5)
- Transportation (2)
Media Contacts
![(From left) ORNL Associate Laboratory Director for Computing and Computational Sciences Jeff Nichols; ORNL Health Data Sciences Institute Director Gina Tourassi; DOE Deputy Under Secretary for Science Thomas Cubbage; ORNL Task Lead for Biostatistics Blair Christian; and ORNL Research Scientist Ioana Danciu were invited to the White House to showcase an ORNL-developed digital tool aimed at better matching cancer patients with clinical trials.](/sites/default/files/styles/list_page_thumbnail/public/2019-03/TourassiWH%5B1%5D.png?h=26b5064d&itok=HUC2iYmE)
OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.